Swedish digital health start-up Doktor.se secures a further €29.5 million for the global expansion of its services.

The startup Stockholm-based Doktor.se has secured €29.5 million in funding from Chinese technology group Tencent Holdings. Of the total amount raised, €23 million will be new capital and €6.5 million will come from existing shareholders, to be operating in more than seven countries by end of 2021. The funding comes in the form of an […]

Student mental health start-up Mantra Health expands its offering to include teletherapy services for bipolar I disorder

Student-focused New York-based Mantra Health recently unveiled a new programme to support people with bipolar I disorder, just over a year after adding support for patients with bipolar II disorder to its platform. The healthtech company is offering the solution as part of an integration with its customers’ university health services, paving the way towards […]

Moletest offers clinicians an innovative, CE-marked melanoma screening test

Moletest, an Edinburgh-based healthtech company, is offering nomela, a CE-marked screening test for pigmented skin lesions suspected of melanoma, to healthcare professionals nationwide.  The solution aims to offer healthcare providers the ability to reduce dermatology referrals to secondary care through its rapid process involving the taking of high-quality images and the provision of immediate analysis […]

Thymia raises $1.1m for video game-inspired tool to assess and track depression

Thymia has raised a £780k/$1.1m pre-seed round to scale its platform to assess for and monitor depression. The Thymia technology removes the subjectivity from mental health assessments: instead of answering questionnaires, patients play specially designed video games which use cutting-edge Neuropsychology, Linguistics and Machine Learning to detect signs of depression, as well as monitor whether […]

Revolab’s at-home blood testing digital platform is gaining momentum for expansion

Revolab, winner of the 2020 EIT Digital Venture Program, is ready to expand its at-home blood testing kit and platform across Europe following CE mark approval for its solution. In less than a year, the Lithuanian startup centered on self-monitoring of the user’s overall physical well-being has gone from inception to closing a seed round […]

AmalgamRx secures CE Mark for its insulin titration algorithm

Digital therapeutics company AmalgamRx recently announced that it has received EU CE Mark approval for its insulin titration algorithm, called iSage Rx, and its white-label variants, and concluded a commercialisation agreement with Novo Nordisk. The green light for operation in the EU market comes more than four years after FDA approval in the U.S. for […]

Highlights: Caresyntax raises €83 million for surgical AI tool, InterSystems partners with Cognetivity and other latest news.

CARESYNTAX raises €83 million in a Series C funding round for the development of its AI-based surgical tool.  German healthtech company Caresyntax has raised €82.8 million in a Series C funding round. This latest round, led by PFM Health Sciences LP, Optum Ventures, Intel Capital and Lauxera Capital Partners, is one of the largest ever […]

Headway raises $70 million in Series B funding round to develop its mental health platform

The pandemic has certainly highlighted the importance of mental health. Covid-19 has brought many people down with illness or worse, but it has also brought increased isolation, economic uncertainty and many other kinds of disappointment, and all of this has had a ripple effect on our collective and individual state of mind. Headway focuses on […]

Proximie secures $38m in Series B funding round for AR surgery

London-based Proximie, which enables surgeons to share clinical practices through AR, has secured US$38 million to further develop its healthtech platform.   F-Prime Capital led the Series B round, followed by Questa Capital, Eight Roads, Maverick Ventures, Global Ventures, BECO Capital and Cedar Mundi Ventures. This round brings the company’s total funding to $49 million. Founded […]

Slush and AstraZeneca To Double Down Shared Activities In 2021

Slush, a global startup movement and a not-for-profit community, announced a partnership, with a global, science-led biopharmaceutical company AstraZeneca. The collaboration helps Slush’s mission of helping the next generation groundbreaking founders and AstraZeneca’s pioneering work in the healthcare landscape to improve patients’ lives and push the boundaries of science. Slush and AstraZeneca’s collaboration started initially […]